Results 81 to 90 of about 5,789 (161)
Facioscapulohumeral dystrophy (FSHD) is an autosomal dominant muscular dystrophy in which no mutation of pathogenic gene(s) has been identified. Instead, the disease is, in most cases, genetically linked to a contraction in the number of 3.3 kb D4Z4 ...
Weihua Zeng +17 more
doaj +1 more source
FRG2, an FSHD candidate gene, is transcriptionally upregulated in differentiating primary myoblast cultures of FSHD patients. [PDF]
Contains fulltext : 58455.pdf (Publisher’s version ) (Closed access)BACKGROUND: Autosomal dominant facioscapulohumeral muscular dystrophy (FSHD) is associated with partial deletion of the subtelomeric D4Z4 repeat array on chromosome ...
Figlewicz, D. +10 more
core +1 more source
FSHD: a disorder of muscle gene derepression.
Facioscapulohumeral muscular dystrophy (FSHD), the third most common myopathy, is an autosomal dominant disease with an insidious onset and progression. Almost all FSHD patients carry deletions of an integral number of tandem 3.3 kb repeats, termed D4Z4,
DAVIDE GABELLINI, TUPLER, Rossella
core
Advances in the development of a methylation assay for FSHD
Facioscapulohumeral muscular dystrophy is a disease linked to an epigenetic defect in the chromosome 4q subtelomere. This dystrophy is caused by contraction of the D4Z4 macrosatellite array on chromosome 4qter in FSHD1, or by functional impairment of ...
Lemmers RJ +10 more
core
Development of a new methylation assay for FSHD diagnosis
FSHD is linked to chromosomal 4q35 region, that contains a D4Z4 array of up to 200 units. The most common form, autosomal dominant FSHD1, is caused by a contraction of the 4q D4Z4 array to less than 11 units, whereas FSHD2 is caused by reduced levels of ...
Lemmers RJ +10 more
core
WNT pathway alterations in FSHD [PDF]
DUX4 is a potent transcription factor that initiates a large gene deregulation cascade in FSHD muscle cells but most of the cellular pathways causing the pathology are still unknown.
Coppée, Frédérique +7 more
core +1 more source
Facioscapulohumeral muscular dystrophy (FSHD) is a muscular dystrophy that can affect individuals of all age groups. Its prevalence is reported to be 0.4-1 in 10,000 people. Because of the low occurrence of FSHD, anaesthetic management is primarily based
Mete Manici +4 more
doaj +1 more source
Caveolar proteins : putative FSHD biomarkers
Facioscapulohumeral muscular dystrophy (FSHD) is linked to chromatin opening and DNA hypomethylation at the D4Z4 repeat array in the 4q35 subtelomeric region.
Leroy, Baptiste +5 more
core +1 more source
Facioscapulohumeral muscular dystrophy (FSHD) is an autosomal dominant genetic disease, which is caused by the mistaken expression of double homeobox protein 4 protein 4 (DUX4) in skeletal muscle.
Qi Xie, Guangmei Ma, Yafeng Song
doaj +1 more source
Respiratory pattern in a FSHD pediatric population
Facioscapulohumeral muscular dystrophy (FSHD) is an autosomal dominant inherited disorder characterized by selective weakness of face and upper arms and girdle.
FIORILLO, CHIARA +6 more
core +1 more source

